Pharma Stocks Outlook for the week - 21 to 24.08.2017
Pharma Stocks Outlook for the week - 21 to 24.08.2017
( www.rupeedesk.in )
Stocks of pharmaceutical companies may rise next week as fund managers are likely to accumulate these stocks given cheap valuations and as a hedge against the current volatility in the broader market. The downward momentum in pharmaceutical stocks has receded over the past week, but strong buying interest is yet to emerge. The technical point of view, many pharmaceutical companies' shares offer good opportunity for investors to accumulate these stocks. Stocks of top pharmaceutical
companies like Sun Pharmaceutical Industries, Dr Reddy's Laboratories, Lupin, Glenmark Pharmaceuticals, Divi's Laboratories and Cipla have fallen 0.6-36.7% in 2017 so far. One can expect investors to accumulate these stocks as they offer very good margin of safety. Sun Pharma shares are expected to bounce back after falling nearly 12% in August so far. A similar bounce back is expected in Aurobindo Pharma's stock next week. The stock has risen nearly 5% since June as it received a raft of product approvals from the US Food and Drug Administration. Aurobindo Pharma's better product offerings in the US will hold it in good stead compared with some of its peers. The direction of stocks could also be swayed by political developments in the US as any rollback of the proposed repeal bill for Affordable Health Care Act will be positive for Indian drug companies.
Source : Cogencis Information Services Ltd.
Free Intraday Tips : Join Our Whatsapp No : 9841986753
Free Commodity Tips : Join our Whatsapp No : 9094047040
Pharma Stocks Outlook for the week - 21 to 24.08.2017
( www.rupeedesk.in )
Stocks of pharmaceutical companies may rise next week as fund managers are likely to accumulate these stocks given cheap valuations and as a hedge against the current volatility in the broader market. The downward momentum in pharmaceutical stocks has receded over the past week, but strong buying interest is yet to emerge. The technical point of view, many pharmaceutical companies' shares offer good opportunity for investors to accumulate these stocks. Stocks of top pharmaceutical
companies like Sun Pharmaceutical Industries, Dr Reddy's Laboratories, Lupin, Glenmark Pharmaceuticals, Divi's Laboratories and Cipla have fallen 0.6-36.7% in 2017 so far. One can expect investors to accumulate these stocks as they offer very good margin of safety. Sun Pharma shares are expected to bounce back after falling nearly 12% in August so far. A similar bounce back is expected in Aurobindo Pharma's stock next week. The stock has risen nearly 5% since June as it received a raft of product approvals from the US Food and Drug Administration. Aurobindo Pharma's better product offerings in the US will hold it in good stead compared with some of its peers. The direction of stocks could also be swayed by political developments in the US as any rollback of the proposed repeal bill for Affordable Health Care Act will be positive for Indian drug companies.
Source : Cogencis Information Services Ltd.
